
RECURRENT INCREASED NUCHAL TRANSLUCENCY:
A FIRST TRIMESTER PRESENTATION OF
FAMILIAL 13p SATELLITE DELETION Uzun I, Has R, Alici E, Ozdemir M, İnan C, Erzincan S *Corresponding Author: Dr. Isil Uzun, Department of Obstetrics and Gynecology, Acibadem Hospital, Halit
Ziya Usakhıgil Street, Bakırkoy, İstanbul, Turkey. Tel: +90-212-414-4400. Fax: +90-212-414-4152. E-mail:
isiluzu@gmail.com page: 103
|
DISCUSSION
Chromosome 13 is one of the acrocentric chromosomes
of the human karyotype, which also include
chromosomes 14, 15, 21, and 22. The acrocentric
chromosomes are the most variable chromosomes
in the human karyotype. There is considerable shuffling
of various repetitive DNA sequences consisting
of the pericentromeric, short arm and satellite
regions of these chromosomes. Variations include
staining and/or size of the pericentromeric regions,
short arms and satellites, as well as variation in the
number and/or size of nucleolar organizing regions.
None of these variations appear to have any clinical
consequences [1].
Nielsen et al. [2] reported two cases with 13p
satellite deletions in their population study. The first
case was totally normal; however, deviant behavior
and criminality were observed in the second case.
Studies indicate that the frequency of short arm satellites
in acrocentric chromosomes in the population
is between 0.5 and 1.0 per 1000 persons and that the
lack of short arm satellite material does not have any
deleterious effects on the phenotype [2]. In our case,
13p satellite deletions were detected in both maternal
and paternal karyotypes. The couple was not related
to each other in any way.
To the best of our knowledge, this is the first report
of a first trimester presentation of a 13p satellite
deletion. The deletion is thought to be associated with
enlarged NT; however, a congenital heart defect or
other structural abnormalities known to cause nuchal
edema was absent.
Increased NT is defined as an important marker
for fetal chromosomal abnormalities and is used as
a routine first-trimester screening test in many countries
[3,4]. Some of the cases with increased NT are
linked to submicroscopic chromosomal abnormalities
that are typically missed by conventional karyotyping.
Approximately 12.5% of fetuses with increased
NT and an apparently normal karyotype have submicroscopic
chromosomal abnormalities that are likely
to be pathological [5].
The risk of genetic syndromes or neurodevelopmental
delays in fetuses with increased NT at the
first trimester and with normal karyotype is not yet
well established. A systematic review demonstrated
a 4.0% [95% confidence interval (95% CI) (2.0-7.0)
incremental yield for isolated NT. The most common
pathogenic copy number variations reported
were 22q11.2 deletion, 22q11.2 duplication, 10q26.
12q26.3 deletion and 12q21q22 deletion [6]. In this
report, increased NT in both cases are probably related
to 13p presentation. Perinatologists should consider 13p satellite deletions in their differential
diagnoses in the event of an enlarged NT when this
appears to be an isolated finding.
Short arm satellites in acrocentric chromosomes
as 13p satellite deletions may be a cause of increased
NT. It should be noted that this is a relatively frequent
phenomenon. This case demonstrates the importance
of genetic counseling, karyotyping and microarray
testing in the case of markedly increased NT. Non
invasive prenatal testing via cell-free DNA is not
adequate for increased NT. Correct diagnosis will
help in the management of the present pregnancy
and in counseling for future pregnancies.
Declaration of Interest. The authors report no
conflicts of interest. The authors alone are responsible
for the content and writing of this article.
|
|
|
|



 |
Number 27 VOL. 27 (2), 2024 |
Number 27 VOL. 27 (1), 2024 |
Number 26 Number 26 VOL. 26(2), 2023 All in one |
Number 26 VOL. 26(2), 2023 |
Number 26 VOL. 26, 2023 Supplement |
Number 26 VOL. 26(1), 2023 |
Number 25 VOL. 25(2), 2022 |
Number 25 VOL. 25 (1), 2022 |
Number 24 VOL. 24(2), 2021 |
Number 24 VOL. 24(1), 2021 |
Number 23 VOL. 23(2), 2020 |
Number 22 VOL. 22(2), 2019 |
Number 22 VOL. 22(1), 2019 |
Number 22 VOL. 22, 2019 Supplement |
Number 21 VOL. 21(2), 2018 |
Number 21 VOL. 21 (1), 2018 |
Number 21 VOL. 21, 2018 Supplement |
Number 20 VOL. 20 (2), 2017 |
Number 20 VOL. 20 (1), 2017 |
Number 19 VOL. 19 (2), 2016 |
Number 19 VOL. 19 (1), 2016 |
Number 18 VOL. 18 (2), 2015 |
Number 18 VOL. 18 (1), 2015 |
Number 17 VOL. 17 (2), 2014 |
Number 17 VOL. 17 (1), 2014 |
Number 16 VOL. 16 (2), 2013 |
Number 16 VOL. 16 (1), 2013 |
Number 15 VOL. 15 (2), 2012 |
Number 15 VOL. 15, 2012 Supplement |
Number 15 Vol. 15 (1), 2012 |
Number 14 14 - Vol. 14 (2), 2011 |
Number 14 The 9th Balkan Congress of Medical Genetics |
Number 14 14 - Vol. 14 (1), 2011 |
Number 13 Vol. 13 (2), 2010 |
Number 13 Vol.13 (1), 2010 |
Number 12 Vol.12 (2), 2009 |
Number 12 Vol.12 (1), 2009 |
Number 11 Vol.11 (2),2008 |
Number 11 Vol.11 (1),2008 |
Number 10 Vol.10 (2), 2007 |
Number 10 10 (1),2007 |
Number 9 1&2, 2006 |
Number 9 3&4, 2006 |
Number 8 1&2, 2005 |
Number 8 3&4, 2004 |
Number 7 1&2, 2004 |
Number 6 3&4, 2003 |
Number 6 1&2, 2003 |
Number 5 3&4, 2002 |
Number 5 1&2, 2002 |
Number 4 Vol.3 (4), 2000 |
Number 4 Vol.2 (4), 1999 |
Number 4 Vol.1 (4), 1998 |
Number 4 3&4, 2001 |
Number 4 1&2, 2001 |
Number 3 Vol.3 (3), 2000 |
Number 3 Vol.2 (3), 1999 |
Number 3 Vol.1 (3), 1998 |
Number 2 Vol.3(2), 2000 |
Number 2 Vol.1 (2), 1998 |
Number 2 Vol.2 (2), 1999 |
Number 1 Vol.3 (1), 2000 |
Number 1 Vol.2 (1), 1999 |
Number 1 Vol.1 (1), 1998 |
|
|